Treating osteoarthritis in the elderly: should recent data on NSAIDs change our way of practice?
Singh
Harinder
H
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D016208:Databases, Factual; D004008:Diclofenac / Q000009:adverse effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D007783:Lactones / Q000009:adverse effects; D009203:Myocardial Infarction / Q000139:chemically induced; D010003:Osteoarthritis / Q000188:drug therapy*; D012189:Retrospective Studies; D013450:Sulfones / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D004008:Diclofenac; D007052:Ibuprofen